Invesco Pharmaceuticals ETF Rating → The Gold Grab of the Century (From Colonial Metals) (Ad) Free PJP Stock Alerts $76.40 +0.75 (+0.99%) (As of 04/26/2024 08:53 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy2.74Holdings in PJP have an aggregate rating of Moderate Buy based on 221 analyst ratings issued in the past year covering 21 companies (96.3% of the portfolio).PJP Aggregate Price Target$100.1631.10% UpsideHigh Prediction$117.52Average Prediction$100.16Low Prediction$82.52Holdings in PJP have an aggregate price target of $100.16 and a range of $82.52 to $117.52 covering 21 companies (96.3% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PJP Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.88%GERNGeron$3.79+6.5%3 of 5 stars3.00$5.33 40.7%3Short Interest ↑6.23%MRKMerck & Co., Inc.$131.20+0.4%5 of 5 stars2.58$131.33 0.1%12Earnings ReportAnalyst ReportAnalyst Revision5.82%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings5.78%ABBVAbbVie$159.62-4.6%5 of 5 stars2.77$176.08 10.3%13Earnings Report5.77%AMGNAmgen$269.98+0.2%5 of 5 stars2.53$297.40 10.2%19Upcoming Earnings5.71%REGNRegeneron Pharmaceuticals$883.20-0.8%5 of 5 stars2.70$977.77 10.7%20Upcoming Earnings5.65%JNJJohnson & Johnson$146.14-0.5%5 of 5 stars2.46$175.86 20.3%135.56%PFEPfizer$25.40+0.6%5 of 5 stars2.38$36.33 43.0%16Upcoming EarningsDividend Announcement5.56%ABTAbbott Laboratories$107.53+0.6%5 of 5 stars2.67$121.50 13.0%94.19%ANIPANI Pharmaceuticals$65.36+0.6%4 of 5 stars3.00$80.00 22.4%4Short Interest ↑4.15%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming Earnings3.94%SUPNSupernus Pharmaceuticals$30.07+2.6%4 of 5 stars3.00$41.00 36.3%13.84%PBHPrestige Consumer Healthcare$70.47+0.5%4 of 5 stars2.50$110.00 56.1%23.71%CORTCorcept Therapeutics$22.80+2.7%5 of 5 stars3.00$39.30 72.4%4Upcoming EarningsGap Up3.66%LGNDLigand Pharmaceuticals$70.57+0.3%5 of 5 stars3.00$116.33 64.8%3Short Interest ↑3.65%PRGOPerrigo$31.94+2.1%5 of 5 stars3.00$40.67 27.3%3Positive News3.48%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportShort Interest ↓Analyst Revision3.41%GILDGilead Sciences$65.42+0.2%5 of 5 stars2.35$83.87 28.2%17Earnings ReportDividend AnnouncementAnalyst ReportShort Interest ↓Analyst Revision3.22%PCRXPacira BioSciences$26.33+3.3%5 of 5 stars3.00$49.50 88.0%10Upcoming EarningsAnalyst Revision3.20%JAZZJazz Pharmaceuticals$109.46+1.9%5 of 5 stars2.85$195.08 78.2%13Upcoming Earnings2.93%AMPHAmphastar Pharmaceuticals$41.11+0.7%5 of 5 stars2.50$66.00 60.5%4Short Interest ↑Positive News This page (NYSEARCA:PJP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryHas Jeff Bezos Found the Next Nvidia?InvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
